European Healthtech startup funding raised during October 2021.
In October 2021, 63 European Healthtech companies raised a combined €853M across 64 funding rounds, up 34.9% versus October 2020. France led by capital raised, and BGF was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| DNA Script | Series C | Oct 2021 | €142M |
| DentalMonitoring | Other | Oct 2021 | €129M |
| MindMaze | Other | Oct 2021 | €108M |
| IOmx Therapeutics | Series B |
| IPO |
| Oct 2021 |
| €173M |
| Oct 2021 |
| €65M |
| Abalos Therapeutics | Series A | Oct 2021 | €43M |
| Sphere Fluidics | Other | Oct 2021 | €34M |
| Micreos | Other | Oct 2021 | €32M |
| Ultimovacs | Growth/Late | Oct 2021 | €28M |
| Precisis | Other | Oct 2021 | €20M |
| VarmX | Other | Oct 2021 | €18M |
| Rejuvenate Boimed | Series B | Oct 2021 | €16M |
| Sapreme Technologies | Series A | Oct 2021 | €15M |
| OneProjects | Other | Oct 2021 | €15M |
| Naturopéra | Other | Oct 2021 | €14M |
| Leucid Bio | Series A | Oct 2021 | €14M |
